BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 34979750)

  • 1. ALK-TPM3 rearrangement in adult renal cell carcinoma: a case report and literature review.
    Yang J; Dong L; Du H; Li XB; Liang YX; Liu GR
    Diagn Pathol; 2019 Oct; 14(1):112. PubMed ID: 31627758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of Renal Cell Carcinoma Harboring
    Woo CG; Yun SJ; Son SM; Lim YH; Lee OJ
    Yonsei Med J; 2020 Mar; 61(3):262-266. PubMed ID: 32102128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ALK-rearranged renal cell carcinoma (ALK-RCC): Evaluation of histomorphological and immunohistochemical features by analysis of 276 renal cell carcinoma cases in Turkey.
    Doğan K; Onder E
    Pathol Res Pract; 2024 Jan; 253():154951. PubMed ID: 38039739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct Clinicopathologic Features and Possible Pathogenesis of Localized ALK-positive Histiocytosis of the Breast.
    Osako T; Kurisaki-Arakawa A; Dobashi A; Togashi Y; Baba S; Shiozawa S; Ishigame H; Ishige H; Ohno S; Ishikawa Y; Takeuchi K
    Am J Surg Pathol; 2022 Mar; 46(3):344-352. PubMed ID: 34482333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tyrosine kinase alterations in colorectal cancer with emphasis on the distinct clinicopathological characteristics.
    Okano S; Yamashiro Y; Onagi H; Sasa K; Hayashi T; Takahashi M; Sugimoto K; Sakamoto K; Yao T; Saito T
    Histopathology; 2023 Nov; 83(5):733-742. PubMed ID: 37503542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malakoplakia with aberrant ALK expression by immunohistochemistry: a case report.
    Zhang XY; Li J; Chen SL; Li Y; Wang H; He JH
    Diagn Pathol; 2023 Aug; 18(1):97. PubMed ID: 37644531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local ALK-Positive Histiocytosis With Unusual Morphology and Novel
    Tran TAN; Chang KTE; Kuick CH; Goh JY; Chang CC
    Int J Surg Pathol; 2021 Aug; 29(5):543-549. PubMed ID: 33243034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anaplastic lymphoma kinase overexpression enhances aggressive phenotypic characteristics of endometrial carcinoma.
    Yokoi A; Nakamura Y; Hashimura M; Oguri Y; Matsumoto T; Nakagawa M; Ishibashi Y; Ito T; Ohhigata K; Harada Y; Fukagawa N; Saegusa M
    BMC Cancer; 2023 Aug; 23(1):765. PubMed ID: 37592266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [ALK positive histiocytosis with multiple system involvement: report of a case].
    Yao S; Zhang F; Chen Y; Liu YH
    Zhonghua Bing Li Xue Za Zhi; 2024 May; 53(5):495-497. PubMed ID: 38678335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ALK-Positive Histiocytosis: A Case Report and Literature Review.
    Jaber OI; Jarrah DA; Hiasat M; Hussaini MA
    Turk Patoloji Derg; 2021; 37(2):172-177. PubMed ID: 33973641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case report: Systemic presentation of ALK-positive Histiocytosis.
    Wei Y; Zhang R; Lin D; Chen X; Li L; Huang H
    Front Oncol; 2024; 14():1366766. PubMed ID: 38706599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal cell carcinoma with fibromyomatous stroma: A uncommon and rare case.
    Zhao Y; Tao B; He Y; Wang L
    Asian J Surg; 2024 Apr; ():. PubMed ID: 38641536
    [No Abstract]   [Full Text] [Related]  

  • 13. ALK-rearranged renal cell carcinoma with a novel PLEKHA7-ALK translocation and metanephric adenoma-like morphology.
    Hang JF; Chung HJ; Pan CC
    Virchows Arch; 2020 Jun; 476(6):921-929. PubMed ID: 31993771
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Wangsiricharoen S; Zhong M; Ranganathan S; Matoso A; Argani P
    Int J Surg Pathol; 2021 Oct; 29(7):808-814. PubMed ID: 33729862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted next-generation sequencing revealed distinct clinicopathologic and molecular features of VCL-ALK RCC: A unique case from an older patient without clinical evidence of sickle cell trait.
    Wang XT; Fang R; Ye SB; Zhang RS; Li R; Wang X; Ji RH; Lu ZF; Ma HH; Zhou XJ; Xia QY; Rao Q
    Pathol Res Pract; 2019 Nov; 215(11):152651. PubMed ID: 31563285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ALK rearrangement in TFE3-positive renal cell carcinoma: Alternative diagnostic option to exclude Xp11.2 translocation carcinoma.
    Zhu Y; Liu N; Guo W; Pu X; Guo H; Gan W; Li D
    Pathol Res Pract; 2020 Dec; 216(12):153286. PubMed ID: 33197836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ALK rearranged renal cell carcinoma (ALK-RCC): a multi-institutional study of twelve cases with identification of novel partner genes CLIP1, KIF5B and KIAA1217.
    Kuroda N; Trpkov K; Gao Y; Tretiakova M; Liu YJ; Ulamec M; Takeuchi K; Agaimy A; Przybycin C; Magi-Galluzzi C; Fushimi S; Kojima F; Sibony M; Hang JF; Pan CC; Yilmaz A; Siadat F; Sugawara E; Just PA; Ptakova N; Hes O
    Mod Pathol; 2020 Dec; 33(12):2564-2579. PubMed ID: 32467651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anaplastic lymphoma kinase-translocation renal cell carcinoma: clinical and pathological analysis].
    Di SH; Wang XT; Xia QY; Lu ZF; Ma HH; Zhang RS; Wang X; Rao Q
    Zhonghua Bing Li Xue Za Zhi; 2022 Jan; 51(1):28-32. PubMed ID: 34979750
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.